The murine cytomegalovirus protein pp89, which is encoded by gene iel, is a nonstructural regulatory protein expressed in the immediate-early phase of the viral replication cycle and located mainly in the nucleus of infected cells. Protection of BALB/c (H-2d) mice against a lethal murine cytomegalovirus challenge infection is achieved by vaccination with a recombinant vaccinia virus, MCMV-ieI-VAC, expressing pp89 as the only murine cytomegalovirus gene product. The protection is entirely mediated by T lymphocytes of the CD8+ subset. In the present report, we analyzed the molecular basis of the recognition of pp89 by BALB/c CD8+ cytolytic T lymphocytes. A series of internal and terminal deletion mutants of gene ieI was constructed and cloned in vaccinia virus, and the antigenicity and immunogenicity of the fragments of pp89 expressed by the recombinants were studied. A region of only one-sixth of the protein, from amino acids 154 to 249 and encoded by the fourth exon of gene iel, was sufficient for both the recognition in vitro of the protein by pp89-specific cytotoxic T lymphocytes and the induction in vivo of pp89-specific cytotoxic T lymphocytes. By using synthetic peptides, the sequence between residues 161 and 179, which is located within the defined domain, was identified as an epitope presented to BALB/C cytotoxic T lymphocytes by the class I major histocompatibility antigen LU.
Cytomegalovirus (CMV) is an ubiquitous human pathogen that is responsible for congenital malformations and causes serious disease in patients immunocompromised during organ transplantation or as a consequence of infection with human immunodeficiency virus. Adequate and efficient methods of prevention or treatment of CMV disease are lacking (21, 23, 24) . Recovery from CMV disease correlates with a cellular immune response rather than with the presence of CMV-neutralizing antibodies (22, 25) .
The infection of the mouse with murine CMV (MCMV) serves as a model to study antiviral function and antigen specificity of different lymphocyte subsets (10, 15, 17, (27) (28) (29) (30) 41) . By adoptive transfer experiments, it was shown that T lymphocytes limit virus replication and prevent histopathology (30) . In particular, a protective effect against lethal MCMV disease can be ascribed to CD8+ T lymphocytes specific for immunodominant antigens expressed in the immediate-early (IE) phase of the viral replication cycle (28, 29) .
Within the 235-kilobase-pair MCMV DNA (7), gene expression during the IE phase is limited to a region of 12 kilobase pairs, which includes the transcription units iel, ie2, and ie3 (11, 12) . Gene iel contained in transcription unit iel encodes the major MCMV IE protein, the nonstructural regulatory phosphoprotein pp89 (13) . Virus-specific, major histocompatibility complex class I-restricted cytolytic T lymphocytes (CTL) recognize pp89 (15, 17, 41) . Vaccination with a -recombinant vaccinia virus, MCMV-ieI-VAC, expressing pp89 as the only MCMV protein, induces protective immunity (10, 41) .
The reason why IE antigens represent immunodominant antigens for CD8+ T lymphocytes (28) is unknown. Transcription units iel and ie3 give rise to related transcripts and proteins, due to the differential usage of at least five exons. There is evidence for common usage of the transcription start site and the first three exons, the first of which serves as nontranslated leader (12, 13) . Gene ieI, which encodes pp89, comprises the first four exons (13) . Recognition by CD8+ T lymphocytes of amino acid sequences encoded by the second and third exon could offer an explanation for the immunodominance of IE antigens, because several IE proteins in addition to pp89 share these sequences.
Domains and epitopes of a protein antigen recognized by CD8+ T lymphocytes can be defined either by the expression of protein fragments in target cells (37) (38) (39) 43) or by incubation of target cells with synthetic peptides derived from the amino acid sequence of the protein (38, 40, 43) . In this communication, the combination of both methods allowed us to conclude that a single domain of pp89 is relevant for recognition by CD8+ T lymphocytes in BALB/c mice and led to the identification of an epitope 19 amino acids in length within this domain. The domain is entirely encoded by the fourth exon of gene ieI and contains the sequences essential for both immunogenicity and antigenicity of pp89.
(MEF) and partially purified by sucrose gradient centrifugation. Wild (16) was cloned into the Hincll site of the ieI ORF in pEMBL19(+). This plasmid was designated p62/3. In the double-stranded form, p62/3 was used for the construction of the deletion mutants, as described in Results. Single-stranded DNA isolated from supernatants of phage Fl-infected Escherichia coli BMH71-18 harboring p62/3 or the mutated plasmids was used for confirming the accuracy of the deletions by sequencing. Mutated ieI genes were isolated from p62/3 as EcoRI fragments and, after cloning into plasmid pGS62, were inserted into vaccinia virus as described previously (41) .
Immunoprecipitation. L cells infected 12 h before with recombinant vaccinia viruses at a multiplicity of infection of 20 PFU per cell were labeled for 2 h with 170 ,uCi of [35S]methionine per ml in methionine-free medium, and immunoprecipitation of the cell lysates was performed as described previously (14) with serum from mice latently infected with MCMV and antiserum raised in rabbits against the synthetic peptide P(34-53) of pp89 coupled to bovine serum albumin (1, 4) . The immunoprecipitated polypeptides were analyzed by 10 to 20% acrylamide gradient gel electrophoresis.
Synthetic peptides. The peptides were synthesized by using the Merrifield solid-phase techniques on an Applied Biosystems peptide synthesizer and purified by high-pressure liquid chromatography to more than 90% purity (32). They were designated P(x-y), where x and y indicate the Nand C-terminal amino acids, respectively, within the sequence of pp89.
Generation of cytolytic effector cells. The Ld-restricted pp89-specific CTL clone IEl has been described previously (17, 26, 31 (40) . Peptides that were scored negative by this method were additionally tested after a second procedure, in which the already 51Cr-labeled cells were dispensed into 96-well microdilution plates containing the peptides at concentrations up to 100 ,uM. After incubation for 30 min at 37°C, the cytolytic effector cells were added, and the peptides were kept throughout the assay (40) .
RESULTS
Construction of the recombinant vaccinia viruses encoding deletion mutants of pp89 gene iel. The major IE protein of MCMV, pp89, is translated from the major IE mRNA, 2.75 kilobases in length, derived from transcription unit iel of the MCMV genome (11) (12) (13) (14) . We have previously reported the cloning into vaccinia virus of the continuous ieI ORF corresponding to this major mRNA (41) (Fig. 1A) . The pp89 expressed by the recombinant MCMV-ieI-VAC not only is recognized in vitro by MCMV-specific CTL but can also induce pp89-specific CTL in vivo that mediate protective immunity against lethal MCMV challenge (10, 41). The vaccinia virus vector system was now employed for mapping the domains of pp89 that are essential for the antigenicity and the immunogenicity of the protein for major histocompatibility complex class I-restricted CTL. Our strategy was to study the effect that removal of defined regions of pp89 has on the cellular immune response.
A series of deletions spanning altogether 97% of the pp89 sequence were produced within gene ieI cloned in plasmid p62/3, and the mutated genes were recombined into vaccinia virus (Fig. 1B) ieI-(AA)-VAC (abbreviated as AA) was constructed by EcoRV digestion of p62/3. The ieI ORF contains one EcoRV site, and a second EcoRV site is located in the intron that separates the nontranslated leader sequence of the first exon from the protein-coding sequences of the ORF (13). Cleavage resulted in the deletion of the single EcoRV fragment. This isolated EcoRV fragment was digested with HincII, and the shorter EcoRV-HincII fragment containing the translation start site was reintroduced into the p62/3 that lacked the EcoRV fragment. AF was constructed as follows: plasmid p62/3 contains three PvuII sites, only one of which is located in the ieI ORF. A partial PvuII digestion linearized the vector. Subsequent cleavage with EcoRV removed the EcoRV fragment and the EcoRV-PvuII fragment upstream of the PvuII site in the coding region. The isolated EcoRV fragment was then reintroduced at its original position. Although the deletions in AA and AF were sealed by blunt end ligation of fragments, the preparation of the deletion mutants AC, AH, and AJ required the creation of blunt ends by using the Klenow fragment of DNA polymerase I before ligation. To generate mutant AC, cleavage with HindIII and Asp-718 removed all MCMV sequences between the HindIII site in the multiple cloning site of plasmid pEMBL19(+) and the Asp-718 site in the ieI ORF. The isolated HindIII fragment was reintegrated, resulting in the loss of sequences between the HindIII and Asp-718 sites in the ieI ORF. Deletion mutants AJ and AH were also originally intended to express the carboxy terminus of the protein (Fig. 1B) . During the deletion procedure, however, 1 and 2 base pairs, respectively, were lost, thereby causing frameshifts that resulted in the addition of 1 and 16 amino acids, respectively, preceding translation termination codons. AH was constructed by removal of the HincII-XbaI fragment and subsequent reintroduction of the smaller HincII-PvuII subfragment, and AJ was constructed by removal of the HincII-HindIll fragment followed by reintroduction of the HincII-BglII subfragment.
The expression of the pp89 deletion mutants in cells infected with the recombinant vaccinia viruses was confirmed by immunoprecipitation (Fig. 2) . In all cases, the apparent molecular weight of the pp89 fragments was higher than the calculated molecular mass ( Fig. 1 and 2 ). This was not unexpected, because the authentic pp89 is known to migrate by a factor of 1.3 slower than expected from size calculation (13) . If the shift to higher molecular weight of pp89 is due to contributions from certain regions of the protein, we should expect to find different degrees of shift in the different deletion mutants of pp89. Indeed, when the calculated molecular masses were compared with the apparent molecular weights, the factor of 1.3 did not apply to all pp89 variants. In particular, the 35-kilodalton (kDa) fragment of pp89 expressed by the recombinant AH (Fig. 2) had migration properties in between the calculated molecular mass (30 kDa) and the expected apparent molecular mass (40 kDa) . This suggests that the C-terminal region of pp89 missing in AH is perhaps rich in posttranslational modifications. A minor difference in migration properties was also observed in pp89 fragment expressed by the recombinant AF ( Fig. 1 and 2) .
Mapping of the protein for BALB/c CTL. The recognition by BALB/c MCMV-specific CTL of the fragments of pp89 expressed by the recombinant vaccinia viruses was analyzed by using KD2SV cells, which express all H-2d class I molecules. Cells infected with the recombinants AA, AC, and AH were recognized by MCMV-specific polyclonal CTL to the same extent as were those infected by MCMV-ieI-VAC encoding the whole protein (Fig. 3) . On the other hand, cells infected with recombinants AF and AJ and control cells infected with wild-type vaccinia virus were not lysed. The fact that AF was not recognized, whereas AA and AH, which lack regions of pp89 flanking the one that is missing in AF (Fig. 1) , were recognized, indicated that only the domain from amino acids 136 to 249 was essential for the antigenicity of pp89. Moreover, taking into account that AJ was also not recognized, this domain could be further narrowed to pp89 amino acids 154 to 249.
The antigenic domain of pp89 is required for the immunogenicity of the protein in BALB/c mice. We studied next the immunogenic properties of the fragments of pp89 expressed by the recombinant viruses. It has been previously shown that pp89 expressed by the recombinant MCMV-ieI-VAC is able to prime pp89-specific CTL in BALB/c mice (41) . We now found that the pp89 fragments expressed by the recombinants AA, AC, and AH were as effective as the whole protein in eliciting in vivo CTL that recognized pp89 expressed in MCMV-infected cells (Fig. 4) Identification of amino acid sequences recognized by CTL within the domain defined with the deletion mutants. The data presented so far provided only negative evidence as to the location within the protein of the epitopes recognized by CTL. For positive evidence, in parallel to the analysis of the deletion mutants, we screened the pp89 sequence for motifs that could represent epitopes for T lymphocytes (33) . The peptides P(34-53), P(87-104), P(92-106), P(271-295), P(315-328), and P(451-466) were synthesized and tested for their ability to render uninfected cells that express H-2d class I surface glycoproteins susceptible to lysis by pp89-specific CTL. None of these peptides, all of which fortuitously lay outside the domain between amino acids 154 and 249, was recognized by the CTL (data not shown), thus supporting the results obtained with the deletion mutants.
After completion of the deletion analysis, we focused the search for putative epitope sequences on the defined domain, and the peptides P(161-179) and P(197-204) were synthesized and tested. When pulsed with P(161-179), KD2SV cells, which express all H-2d class I molecules, were recognized and lysed by both a polyclonal MCMV-specific CTL population and the pp89-specific, Ld-restricted CTL clone IEl (Fig. 5) . KD2SV well as KD2SV cells incubated without peptides were not lysed. L cells (H-2k), which lack H-2d molecules, were not able to present any of the peptides. We therefore concluded that the region from amino acids 161 to 179 in pp89 constitutes an epitope recognized by H-2d class I-restricted CTL. Since recognition of pp89 by the CTL clone IEl is restricted to the Ld glycoprotein (17, 26), we expected P(161-179) to be presented in association with the Ld molecule. We could not exclude, however, the possibility that it might also be presented by other H-2d class I glycoproteins, since for several epitopes recognized in association with MHC class II glycoproteins presentation by more than one restriction element has been described (18, 35) . polyclonal and clonal CTL (Fig. 6A ). Surface expression of the Ld, Dd, and Kd molecules was confirmed for each of the transfected cell lines by cytofluorometric analysis with the respective monoclonal antibodies specific for Ld, Dd, and Kd (data not shown). In addition, all three MHC class I gene transfectants, but not the untransfected L cells (data not shown), were able to present vaccinia virus antigens to BALB/c vaccinia-specific H-2d-restricted polyclonal CTL (Fig. 6B) , thus providing evidence for the functional integrity of the transfected gene products.
In conclusion, the region from amino acids 154 to 249 of pp89 represents the antigenic and immunogenic domain of the protein for BALB/c MHC class I-restricted CTL and contains an epitope that is recognized after presentation by the Ld molecule (Fig. 7) .
DISCUSSION
Vaccination of mice with a recombinant vaccinia virus, MCMV-ieI-VAC, encoding the IE protein pp89 as the only MCMV gene product (41) , can protect against a lethal challenge infection with MCMV. Protection is mediated by pp89-specific CD8+ T lymphocytes (10). These results led us to study which regions of the IE protein pp89 are immunogenic and antigenic for the virus-specific and MHC class I-restricted CTL response in BALB/c (H-2d) mice. The results show that the pp89-specific CTL response is entirely directed to a domain comprising only one-sixth of the whole protein, located between pp89 residues 154 and 249. An epitope 19 amino acids in length was identified within this region. When presented by the MHC class I glycoprotein Ld, this epitope was recognized by both polyclonal MCMVspecific CTL and the pp89-specific CTL clone IEL.
According to current concepts of antigen processing and presentation for T lymphocytes, most protein antigens undergo intracellular fragmentation yielding short peptides (36, 40) . After binding to a single site on surface MHC molecules (2, 9), such peptides are recognized by the antigen-specific T-cell receptor (34) . Recognition of protein antigens by specific CTL has been demonstrated when target cells either synthesized whole or fragmented proteins after transfection (15, 17, (37) (38) (39) 43) or were incubated with synthetic peptides derived from the amino acid sequence of the protein (38, 40, 43) . By using these strategies, antigenic sequences of some proteins could be defined. Although we have successfully employed the transfection of cells to study the recognition of pp89 by CTL (15, 17) , the use of transfected cell lines is (8) . It has been suggested that these distant regions might be involved in the processing of the protein. If this is the case also in pp89, such regions should also be contained within the defined domain, since deletion of all other regions affected neither the antigenicity nor the immunogenicity of the protein.
The domain is encoded entirely by the fourth exon of gene iel in transcription unit iel. mRNA selected by DNA sequences from the transcription unit ie3 and translated into protein does not hybridize to the fourth exon (12, 13) . Thus, ie3 products cannot contribute to the pp89-specific CTL response. Previous work has identified proteins of 67, 51, and 31 kDa in size that contain sequences derived from the first three exons of transcription unit iel (12, 13) . In addition, all of them share with pp89 the monoclonal antibody 6/20/1 binding site (12) (33) . A statistical analysis of several epitopes has revealed a common sequence pattern consisting of a charged amino acid or glycine followed by two or three hydrophobic amino acids and a charged or polar amino acid. We screened the whole pp89 for such motifs, and six selected sequences were synthesized. They all failed to render uninfected H-2d target cells susceptible to lysis by both MCMV-specific polyclonal CTL and the pp89-specific CTL clone IEI. It was not until we had defined the antigenic domain and selected two peptides within it that an epitope recognized by specific polyclonal and clonal CTL was found. The epitope comprises amino acids 161 to 179, contains a proposed pattern at residues 170 to 174, and is the first described to be presented by the major histocompatibility complex class I molecule Ld. Since some degree of similarity is observed for epitopes presented by the same restriction molecule (33), we hope that the identification of this epitope will help in the search for Ld-restricted epitopes in other protein antigens.
An unusual feature of this peptide is the fact that it contains three prolines, an amino acid seldom found in a-helices and in epitopes recognized by T lymphocytes, many of which are supposed to adopt an (x-helical conformation (20, 33) . By studying the recognition by the CTL clone IE1 of shorter or substituted derivatives of this peptide, we expect to find out the optimal length of the epitope and which residues are important for binding to the class I molecule and for interaction with the T-cell receptor.
The recognition of the epitope at residues 161 (42) . The peptide of the nonstructural MCMV IE protein can be tested accordingly.
